Coronary spasm and coronary atherosclerosis: must we choose?

Education debate: clinical diagnostic reasoning.

Internal medicine journal·2011

An evolution-based hypothesis on the origin and mechanisms of autoimmune disease.

Immunology and cell biology·1998

Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogen.

Carcinogenesis·1995

The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-ones.

Carcinogenesis·1995

CYP1 induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: a structure activity relationship.

Toxicology·1995

The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenes.

Toxicology letters·1995

Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome.

Circulation·2026

Metrnl Reduces Thrombosis and Acute Myocardial Injury Through Inhibition of Platelet Activation via CD36 Receptor Degradation.

Circulation·2026

Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.

Circulation·2026

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.

Circulation·2026

Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation.

Circulation·2026

Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation.

Circulation·2026

Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.

Frontiers in cardiovascular medicine·2026

Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.

Frontiers in cardiovascular medicine·2026

PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.

Frontiers in cardiovascular medicine·2026

Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study.

Frontiers in endocrinology·2026

Association of the TyG index and inflammatory burden index with AMR-defined coronary microvascular dysfunction and 12-month MACE after STEMI.

Frontiers in endocrinology·2026

Correlation of Cystatin C- and Creatinine-Based Renal Equations With Lipid Parameters in Chronic Kidney Disease: A Case-Control Study.

Cureus·2026

Related Experiment Videos

Coronary spasm and coronary atherosclerosis: must we choose?

Related Concept Videos

Education debate: clinical diagnostic reasoning.

An evolution-based hypothesis on the origin and mechanisms of autoimmune disease.

Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogen.

The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-ones.

CYP1 induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: a structure activity relationship.

The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenes.

Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome.

Metrnl Reduces Thrombosis and Acute Myocardial Injury Through Inhibition of Platelet Activation via CD36 Receptor Degradation.

Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.

Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation.

Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation.

Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.

Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.

PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.

Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study.

Association of the TyG index and inflammatory burden index with AMR-defined coronary microvascular dysfunction and 12-month MACE after STEMI.

Correlation of Cystatin C- and Creatinine-Based Renal Equations With Lipid Parameters in Chronic Kidney Disease: A Case-Control Study.

Related Experiment Videos

Coronary spasm and coronary atherosclerosis: must we choose?

Related Concept Videos

Related Articles